Novartis and Sandoz Recall Non-Compliant Blister Packs

The prescription drugs were not in child resistant packaging, which put them in violation of the Poison Prevention Packaging Act.

Recalled Packaging
Recalled Packaging

A recent article from The Columbus Dispatch noted the recall of 9 different drugs from Sandoz and Novartis. Apparently both companies were in violation of the Poison Prevention Packaging Act, as their drugs were not properly packaged in child resistant blister packs. The oversight led to a confirmed report of a child ingesting haloperidol from a blister pack.

The recall affects lots sold at clinics and pharmacies nationwide between September 2016 and June 2018. Consumers with affected lots are instructed to secure the blister cards to keep them away from children and contact the companies for further instructions. The affected drugs include: Azithromycin, Donepezil, Haloperidol, Imipramine HCl, Isosorbide Dinitrate, Naratriptan, Ondansetron, Perphenazine, and Risperidone.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report